Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.97 USD | +0.47% | +4.13% | +10.19% |
04-26 | Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference | CI |
04-22 | Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies | MT |
Evolution of the average Target Price on Bruker Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Bruker Corporation
Goldman Sachs | |
UBS | |
JPMorgan Chase | |
Jefferies & Co. | |
Citigroup | |
Leerink Partners | |
Stifel Nicolaus | |
TD Cowen | |
BofA Securities | |
Wolfe Research | |
SVB Leerink | |
Wells Fargo Securities | |
Cleveland Research |
EPS Revisions
- Stock Market
- Equities
- BRKR Stock
- Consensus Bruker Corporation